Ispire-Backed IKE Tech to Spotlight Breakthroughs in Vape Safety and Harm Reduction at World Vape Show Dubai

Rhea-AI Summary

Ispire Technology's joint venture IKE Tech will showcase its innovative vaping safety technologies at the World Vape Show Dubai from June 18-20, 2025. John Patterson, IKE Tech's president and Ispire's SVP of International Nicotine, will participate in a panel on consumer safety and harm reduction alongside industry leaders. The company will highlight its blockchain-based age-gating and Smart-Tag authentication technologies, which achieved 100% effectiveness in preventing underage access during clinical trials. Notably, their age-verification system is under FDA review as the first standalone age-gating system for ENDS (Electronic Nicotine Delivery Systems). The event will feature hands-on demonstrations of their vaping technology, with key executives including Jamie Kennaugh and Alex Yumshtyk in attendance.

President of Ike Tech and SVP of International Nicotine at Ispire, John Patterson, to Join Global Leaders on Industry Innovation Panel

LOS ANGELES, June 16, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a global leader in vaporization technology and precision dosing, announced its joint venture IKE Tech LLC ("IKE Tech") will spotlight Ike Tech's blockchain based point of use age-gating and Smart-Tag authentication technologies at the World Vape Show Dubai, June 18–20, 2025.

John Patterson, president of Ike Tech and senior vice president of International Nicotine at Ispire, will be featured on a high-level panel titled "Innovations in Consumer Safety and Harm Reduction," scheduled for Wednesday, June 18, from 14:15 to 15:15 p.m. (GMT+4). Joining industry peers from Philip Morris Management Services, Salim - Sartoni Associates Ltd, Shenzhen Smoore Technology Co.Ltd and Yunnan University, Patterson will share insights on IKE Tech's biometric, blockchain-enabled platform for continuous age verification—technology that has achieved 100% effectiveness in preventing underage access during clinical trials and was recently accepted for FDA review as the first standalone age-gating system for ENDS.

In addition to the speaking engagement, Ispire and Ike Tech will jointly exhibit at the show, providing hands-on demonstrations of their cutting-edge vaping technology. Attending executives will include:

•  John Patterson, president of Ike Tech and senior vice president of International Nicotine at Ispire
• Jamie Kennaugh, vice president of Sales and Marketing at Ispire
• Alex Yumshtyk, head of Product at Ispire

"Dubai is a critical global market and a hub for regulatory discourse," said Patterson. "We're proud to share how our technologies—grounded in real science and built for public health—are setting new benchmarks in harm reduction and youth prevention. With FDA review underway, we're ready to scale our solution globally."

To schedule a meeting with John Patterson or other Ispire representatives, please email john.p@iketech.com.

About IKE Tech LLC
IKE Tech LLC is a joint venture comprised of three leading technology and research companies -- Ispire Technology Inc, Touch Point Worldwide Inc. d/b/a Berify, and Chemular Inc. -- dedicated to revolutionizing Identity and Age Verification (IAV) technology solutions. Recognizing the absence of a universal point-of-sale IAV solution and recognition of the need for one, these companies joined forces to create a unique IAV technology component. IKE's mission is to set the gold standard for IAV by (i) permitting access to electronic nicotine delivery systems by authorized adult users while (ii) preventing underage access through a "plug and play" component compatible across different devices and platforms.

About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Twitter and YouTube.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE's success of meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the U.S. Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

IR Contacts:
For more information, kindly contact:
Investor Relations
Sherry Zheng
718.213.7386
ir@ispiretechnology.com

KCSA Strategic Communications
Phil Carlson
212.896.1233
ispire@kcsa.com

PR Contact:
Ellen Mellody
570.209.2947
ispire@kcsa.com

 

View original content:https://www.prnewswire.com/news-releases/ispire-backed-ike-tech-to-spotlight-breakthroughs-in-vape-safety-and-harm-reduction-at-world-vape-show-dubai-302480709.html

SOURCE Ispire Technology Inc.

FAQ

What technologies will ISPR's IKE Tech showcase at World Vape Show Dubai 2025?

IKE Tech will showcase its blockchain-based point of use age-gating and Smart-Tag authentication technologies for vaping products.

What is the effectiveness rate of IKE Tech's age verification system in clinical trials?

IKE Tech's biometric, blockchain-enabled platform for continuous age verification achieved 100% effectiveness in preventing underage access during clinical trials.

When and where will John Patterson speak at the World Vape Show Dubai?

John Patterson will speak on the 'Innovations in Consumer Safety and Harm Reduction' panel on Wednesday, June 18, from 14:15 to 15:15 p.m. (GMT+4).

What is the current FDA status of IKE Tech's age-gating system?

IKE Tech's age-gating system has been accepted for FDA review as the first standalone age-gating system for ENDS (Electronic Nicotine Delivery Systems).